Shanghai Kai Kai Industry Co Ltd B (SHG:900943) — Market Cap & Net Worth

$34.08 Million USD  · Rank #23435

Market Cap & Net Worth: Shanghai Kai Kai Industry Co Ltd B (900943)

Shanghai Kai Kai Industry Co Ltd B (SHG:900943) has a market capitalization of $34.08 Million ($34.08 Million) as of September 21, 2026. Listed on the SHG stock exchange, this China-based company holds position #23435 globally and #4714 in its home market, demonstrating a 0.24% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanghai Kai Kai Industry Co Ltd B's stock price $0.43 by its total outstanding shares 80000000 (80.00 Million). Also see 900943 total assets for a full breakdown of the balance sheet.

Shanghai Kai Kai Industry Co Ltd B Market Cap History: 2015 to 2026

Shanghai Kai Kai Industry Co Ltd B's market capitalization history from 2015 to 2026. Data shows change from $108.75 Million to $34.08 Million (-7.58% CAGR). Also see Shanghai Kai Kai Industry Co Ltd B cash flow conversion for how efficiently the company converts equity into cash flow.

Shanghai Kai Kai Industry Co Ltd B Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Shanghai Kai Kai Industry Co Ltd B's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Shanghai Kai Kai Industry Co Ltd B for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.04x

Shanghai Kai Kai Industry Co Ltd B's market cap is 0.04 times its annual revenue

Industry average: 0.36x Lower than industry average

Latest Price to Earnings (P/E) Ratio

1.25x

Shanghai Kai Kai Industry Co Ltd B's market cap is 1.25 times its annual earnings

Industry average: 6.28x Lower than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2015 $108.75 Million $881.28 Million $19.85 Million 0.12x 5.48x
2016 $103.15 Million $906.06 Million $21.29 Million 0.11x 4.84x
2017 $71.23 Million $962.10 Million $38.73 Million 0.07x 1.84x
2018 $53.99 Million $877.57 Million $35.23 Million 0.06x 1.53x
2019 $37.70 Million $870.40 Million $21.98 Million 0.04x 1.72x
2020 $35.76 Million $761.82 Million $13.67 Million 0.05x 2.62x
2021 $38.39 Million $669.83 Million $21.72 Million 0.06x 1.77x
2022 $45.98 Million $894.17 Million $39.95 Million 0.05x 1.15x
2023 $35.12 Million $925.07 Million $39.30 Million 0.04x 0.89x
2024 $43.68 Million $1.09 Billion $35.00 Million 0.04x 1.25x

Competitor Companies of 900943 by Market Capitalization

Companies near Shanghai Kai Kai Industry Co Ltd B in the global market cap rankings as of September 21, 2026. Review tangible net worth ratio of Shanghai Kai Kai Industry Co Ltd B to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Shanghai Kai Kai Industry Co Ltd B by market ranking:

  • H+M HEN.+MAU.UNSP.ADR 1/5 (F:HMSA): Ranked #1035 globally with a market cap of $26.09 Billion USD ( €22.31 Billion EUR).
  • H & M Hennes & Mauritz AB (publ) (ST:HM-B): Ranked #1097 globally with a market cap of $24.52 Billion USD ( Skr227.82 Billion SEK).
  • Ralph Lauren Corp Class A (NYSE:RL): Ranked #1868 globally with a market cap of $12.63 Billion USD.
  • LPP S.A. (WAR:LPP): Ranked #1902 globally with a market cap of $12.34 Billion USD ( zł44.84 Billion PLN).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#1035 H+M HEN.+MAU.UNSP.ADR 1/5 F:HMSA $26.09 Billion €3.18
#1097 H & M Hennes & Mauritz AB (publ) ST:HM-B $24.52 Billion Skr162.50
#1868 Ralph Lauren Corp Class A NYSE:RL $12.63 Billion $335.10
#1902 LPP S.A. WAR:LPP $12.34 Billion zł24160.00

Shanghai Kai Kai Industry Co Ltd B Historical Marketcap From 2015 to 2026

Between 2015 and today, Shanghai Kai Kai Industry Co Ltd B's market cap moved from $108.75 Million to $ 34.08 Million, with a yearly change of -7.58%.

Year Market Cap Change (%)
2026 $34.08 Million -12.35%
2025 $38.88 Million -10.99%
2024 $43.68 Million +24.37%
2023 $35.12 Million -23.61%
2022 $45.98 Million +19.75%
2021 $38.39 Million +7.36%
2020 $35.76 Million -5.16%
2019 $37.70 Million -30.17%
2018 $53.99 Million -24.20%
2017 $71.23 Million -30.94%
2016 $103.15 Million -5.15%
2015 $108.75 Million --

End of Day Market Cap According to Different Sources

On Sep 21st, 2026 the market cap of Shanghai Kai Kai Industry Co Ltd B was reported to be:

Source Market Cap
Yahoo Finance $34.08 Million USD
MoneyControl $34.08 Million USD
MarketWatch $34.08 Million USD
marketcap.company $34.08 Million USD
Reuters $34.08 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Shanghai Kai Kai Industry Co Ltd B

SHG:900943 China Apparel Manufacturing
Market Cap
$34.08 Million
Market Cap Rank
#23435 Global
#4714 in China
Share Price
$0.43
Change (1 day)
+0.47%
52-Week Range
$0.38 - $0.54
All Time High
$1.48
About

Shanghai Kai Kai Industry Company Limited engages in the wholesale and retail of pharmaceutical products in China. The company engages in the wholesale and retail of traditional Chinese and Western medicines; medical devices; reagents; consumables and diagnosis; and treatment services, etc. under the Shang Lei brand, as well as production and sale of Chinese patent medicine under the Jing and Que… Read more